| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arsenic | 54 | 2025 | 261 | 11.000 |
Why?
|
| Environmental Exposure | 34 | 2025 | 334 | 5.110 |
Why?
|
| Water Pollutants, Chemical | 23 | 2022 | 134 | 3.900 |
Why?
|
| Bangladesh | 56 | 2025 | 331 | 3.040 |
Why?
|
| Arsenic Poisoning | 15 | 2019 | 103 | 2.980 |
Why?
|
| Environmental Pollutants | 7 | 2022 | 52 | 2.280 |
Why?
|
| DNA Methylation | 10 | 2025 | 666 | 1.840 |
Why?
|
| Oryza | 5 | 2021 | 42 | 1.770 |
Why?
|
| Drinking Water | 10 | 2022 | 67 | 1.670 |
Why?
|
| Maternal Exposure | 6 | 2021 | 58 | 1.660 |
Why?
|
| Diet | 8 | 2019 | 444 | 1.500 |
Why?
|
| Skin Diseases | 13 | 2019 | 174 | 1.500 |
Why?
|
| Metals | 5 | 2024 | 93 | 1.350 |
Why?
|
| Female | 97 | 2025 | 46587 | 1.260 |
Why?
|
| Polymorphism, Single Nucleotide | 21 | 2021 | 2415 | 1.240 |
Why?
|
| Middle Aged | 79 | 2025 | 26146 | 1.200 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2021 | 159 | 1.180 |
Why?
|
| Cohort Studies | 24 | 2023 | 2886 | 1.160 |
Why?
|
| Pregnancy Outcome | 2 | 2020 | 258 | 1.100 |
Why?
|
| Water Supply | 12 | 2022 | 61 | 1.100 |
Why?
|
| Gene-Environment Interaction | 5 | 2025 | 118 | 1.100 |
Why?
|
| Blood Pressure | 8 | 2020 | 906 | 1.100 |
Why?
|
| Adult | 77 | 2025 | 26816 | 1.100 |
Why?
|
| Male | 84 | 2025 | 42674 | 1.080 |
Why?
|
| Cacodylic Acid | 4 | 2021 | 22 | 1.080 |
Why?
|
| Humans | 121 | 2025 | 89961 | 1.070 |
Why?
|
| Nutrition Surveys | 7 | 2022 | 111 | 1.050 |
Why?
|
| Vital Capacity | 4 | 2021 | 69 | 1.030 |
Why?
|
| Lung | 4 | 2021 | 1292 | 1.030 |
Why?
|
| Epigenesis, Genetic | 5 | 2025 | 521 | 1.010 |
Why?
|
| Groundwater | 2 | 2022 | 14 | 0.970 |
Why?
|
| Metals, Heavy | 3 | 2019 | 15 | 0.950 |
Why?
|
| Environmental Monitoring | 7 | 2024 | 80 | 0.940 |
Why?
|
| Asthma | 2 | 2021 | 984 | 0.850 |
Why?
|
| Allostasis | 1 | 2023 | 2 | 0.850 |
Why?
|
| Genetic Predisposition to Disease | 15 | 2021 | 2360 | 0.840 |
Why?
|
| Cardiovascular Diseases | 9 | 2021 | 716 | 0.840 |
Why?
|
| Aged | 49 | 2025 | 19254 | 0.830 |
Why?
|
| Child | 13 | 2025 | 7240 | 0.820 |
Why?
|
| Telomere | 5 | 2025 | 119 | 0.800 |
Why?
|
| Occupational Exposure | 3 | 2018 | 87 | 0.800 |
Why?
|
| Hypertension | 5 | 2019 | 747 | 0.800 |
Why?
|
| Skin Neoplasms | 6 | 2025 | 598 | 0.800 |
Why?
|
| Forced Expiratory Volume | 2 | 2021 | 126 | 0.800 |
Why?
|
| Selenium | 3 | 2019 | 46 | 0.740 |
Why?
|
| Pesticides | 4 | 2020 | 29 | 0.730 |
Why?
|
| Prospective Studies | 25 | 2020 | 4329 | 0.730 |
Why?
|
| Gravidity | 1 | 2020 | 7 | 0.720 |
Why?
|
| Adolescent | 33 | 2024 | 9340 | 0.710 |
Why?
|
| Metabolic Syndrome | 2 | 2018 | 123 | 0.710 |
Why?
|
| Longitudinal Studies | 20 | 2025 | 1082 | 0.700 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 6 | 2017 | 693 | 0.690 |
Why?
|
| Smoking | 8 | 2019 | 625 | 0.680 |
Why?
|
| Young Adult | 33 | 2025 | 6409 | 0.670 |
Why?
|
| Genome-Wide Association Study | 14 | 2021 | 1691 | 0.650 |
Why?
|
| Cardiotoxins | 1 | 2018 | 3 | 0.640 |
Why?
|
| Manganese | 1 | 2019 | 55 | 0.640 |
Why?
|
| Residence Characteristics | 1 | 2020 | 203 | 0.630 |
Why?
|
| Food | 3 | 2015 | 89 | 0.630 |
Why?
|
| Food Contamination | 5 | 2019 | 34 | 0.620 |
Why?
|
| Risk Factors | 21 | 2023 | 5558 | 0.620 |
Why?
|
| Pregnancy | 8 | 2022 | 3046 | 0.610 |
Why?
|
| Cross-Sectional Studies | 10 | 2021 | 1730 | 0.600 |
Why?
|
| Diabetes Mellitus, Type 2 | 4 | 2024 | 1180 | 0.590 |
Why?
|
| Child Mortality | 1 | 2017 | 6 | 0.590 |
Why?
|
| Potassium Channels, Tandem Pore Domain | 1 | 2017 | 16 | 0.580 |
Why?
|
| Urinalysis | 1 | 2017 | 31 | 0.580 |
Why?
|
| Obesity | 3 | 2021 | 972 | 0.570 |
Why?
|
| Diet, Gluten-Free | 1 | 2017 | 58 | 0.540 |
Why?
|
| Birth Weight | 3 | 2022 | 148 | 0.540 |
Why?
|
| Arsenicals | 5 | 2019 | 48 | 0.530 |
Why?
|
| Antioxidants | 3 | 2013 | 226 | 0.520 |
Why?
|
| Carcinogens | 1 | 2016 | 111 | 0.520 |
Why?
|
| Selenomethionine | 2 | 2013 | 11 | 0.500 |
Why?
|
| Lung Diseases | 2 | 2016 | 275 | 0.500 |
Why?
|
| Proportional Hazards Models | 6 | 2020 | 848 | 0.500 |
Why?
|
| Telomere Homeostasis | 3 | 2021 | 30 | 0.490 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2017 | 168 | 0.480 |
Why?
|
| Leukocytes | 3 | 2025 | 209 | 0.480 |
Why?
|
| Quantitative Trait Loci | 5 | 2021 | 615 | 0.460 |
Why?
|
| United States | 13 | 2024 | 7108 | 0.460 |
Why?
|
| Mendelian Randomization Analysis | 3 | 2021 | 44 | 0.460 |
Why?
|
| Transcriptome | 3 | 2025 | 661 | 0.460 |
Why?
|
| Gene Expression | 2 | 2018 | 1309 | 0.450 |
Why?
|
| CpG Islands | 5 | 2019 | 158 | 0.450 |
Why?
|
| Breast Neoplasms | 8 | 2019 | 3022 | 0.450 |
Why?
|
| Phenotype | 9 | 2024 | 2456 | 0.450 |
Why?
|
| Public Health | 3 | 2022 | 140 | 0.450 |
Why?
|
| Water Wells | 4 | 2022 | 18 | 0.440 |
Why?
|
| Digestive System Neoplasms | 1 | 2013 | 21 | 0.440 |
Why?
|
| alpha-Tocopherol | 1 | 2013 | 9 | 0.430 |
Why?
|
| Body Mass Index | 9 | 2021 | 776 | 0.430 |
Why?
|
| Anticarcinogenic Agents | 1 | 2013 | 73 | 0.410 |
Why?
|
| Water Pollution, Chemical | 3 | 2011 | 21 | 0.400 |
Why?
|
| Methyltransferases | 3 | 2019 | 192 | 0.390 |
Why?
|
| Aging | 4 | 2025 | 727 | 0.390 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2025 | 1284 | 0.390 |
Why?
|
| Genome, Human | 5 | 2019 | 791 | 0.380 |
Why?
|
| Acculturation | 2 | 2023 | 15 | 0.380 |
Why?
|
| Air Pollutants | 2 | 2024 | 96 | 0.370 |
Why?
|
| Child, Preschool | 4 | 2025 | 3771 | 0.350 |
Why?
|
| Vitamin B Complex | 1 | 2010 | 21 | 0.350 |
Why?
|
| Neoplasms | 5 | 2023 | 3065 | 0.340 |
Why?
|
| Gene Expression Profiling | 6 | 2025 | 1452 | 0.340 |
Why?
|
| Genotype | 8 | 2019 | 1852 | 0.330 |
Why?
|
| Ammonia-Lyases | 2 | 2019 | 6 | 0.330 |
Why?
|
| Glutamate Formimidoyltransferase | 2 | 2019 | 6 | 0.330 |
Why?
|
| Gestational Age | 2 | 2021 | 329 | 0.320 |
Why?
|
| Infant | 3 | 2021 | 3188 | 0.310 |
Why?
|
| Genotyping Techniques | 3 | 2019 | 69 | 0.300 |
Why?
|
| Loss of Heterozygosity | 1 | 2008 | 86 | 0.300 |
Why?
|
| Chicago | 3 | 2021 | 1434 | 0.300 |
Why?
|
| Parity | 2 | 2020 | 97 | 0.290 |
Why?
|
| Gene Amplification | 1 | 2008 | 135 | 0.290 |
Why?
|
| Infant, Newborn | 4 | 2020 | 2497 | 0.290 |
Why?
|
| Gene Expression Regulation | 4 | 2018 | 1983 | 0.290 |
Why?
|
| Mexican Americans | 2 | 2024 | 67 | 0.280 |
Why?
|
| Mortality | 3 | 2017 | 149 | 0.270 |
Why?
|
| Odds Ratio | 6 | 2019 | 682 | 0.270 |
Why?
|
| Chromosome Aberrations | 1 | 2008 | 384 | 0.270 |
Why?
|
| Social Class | 1 | 2007 | 137 | 0.270 |
Why?
|
| Prevalence | 7 | 2018 | 1250 | 0.250 |
Why?
|
| Mercury | 1 | 2025 | 12 | 0.250 |
Why?
|
| Nails | 1 | 2025 | 11 | 0.240 |
Why?
|
| Volatile Organic Compounds | 1 | 2024 | 4 | 0.240 |
Why?
|
| Silicones | 1 | 2024 | 20 | 0.240 |
Why?
|
| Wrist | 1 | 2024 | 27 | 0.240 |
Why?
|
| Biomarkers | 5 | 2017 | 1778 | 0.240 |
Why?
|
| Prostatic Neoplasms | 1 | 2016 | 1744 | 0.240 |
Why?
|
| Metabolome | 1 | 2024 | 51 | 0.230 |
Why?
|
| Sex Factors | 4 | 2018 | 1075 | 0.230 |
Why?
|
| Lymphocytes | 1 | 2006 | 468 | 0.230 |
Why?
|
| Life Style | 3 | 2023 | 176 | 0.230 |
Why?
|
| Smoking Cessation | 2 | 2019 | 258 | 0.220 |
Why?
|
| Cadmium | 3 | 2022 | 28 | 0.220 |
Why?
|
| Blood Glucose | 2 | 2024 | 837 | 0.220 |
Why?
|
| Apolipoprotein E4 | 1 | 2023 | 27 | 0.210 |
Why?
|
| Bayes Theorem | 1 | 2025 | 382 | 0.210 |
Why?
|
| Genetic Variation | 3 | 2018 | 1380 | 0.210 |
Why?
|
| Multifunctional Enzymes | 2 | 2019 | 6 | 0.210 |
Why?
|
| United Kingdom | 1 | 2023 | 165 | 0.200 |
Why?
|
| Socioeconomic Factors | 2 | 2018 | 596 | 0.200 |
Why?
|
| Precancerous Conditions | 3 | 2010 | 201 | 0.200 |
Why?
|
| Biological Specimen Banks | 1 | 2023 | 68 | 0.200 |
Why?
|
| Population Health | 1 | 2022 | 33 | 0.200 |
Why?
|
| Molybdenum | 1 | 2022 | 12 | 0.200 |
Why?
|
| Air Pollution | 2 | 2023 | 93 | 0.200 |
Why?
|
| Thinness | 2 | 2014 | 46 | 0.200 |
Why?
|
| Respiration Disorders | 2 | 2013 | 41 | 0.190 |
Why?
|
| Copper | 1 | 2022 | 78 | 0.190 |
Why?
|
| Blood Cells | 1 | 2021 | 33 | 0.190 |
Why?
|
| Databases, Genetic | 3 | 2019 | 269 | 0.190 |
Why?
|
| Incidence | 5 | 2018 | 1603 | 0.190 |
Why?
|
| Telomere Shortening | 1 | 2021 | 25 | 0.190 |
Why?
|
| Regression Analysis | 4 | 2017 | 591 | 0.190 |
Why?
|
| Biomarkers, Tumor | 4 | 2018 | 1545 | 0.180 |
Why?
|
| Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 1 | 2021 | 44 | 0.180 |
Why?
|
| Gonadal Steroid Hormones | 2 | 2023 | 50 | 0.180 |
Why?
|
| Cognitive Dysfunction | 1 | 2023 | 155 | 0.180 |
Why?
|
| Sleep | 1 | 2024 | 455 | 0.180 |
Why?
|
| Water Purification | 1 | 2020 | 3 | 0.180 |
Why?
|
| beta-Globins | 1 | 2019 | 2 | 0.170 |
Why?
|
| Insulin Resistance | 1 | 2022 | 353 | 0.170 |
Why?
|
| Blood | 1 | 2019 | 69 | 0.170 |
Why?
|
| Receptor, EphA4 | 1 | 2019 | 5 | 0.160 |
Why?
|
| Case-Control Studies | 6 | 2018 | 1866 | 0.160 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2021 | 313 | 0.160 |
Why?
|
| Whole Genome Sequencing | 1 | 2019 | 103 | 0.160 |
Why?
|
| Genes, Mitochondrial | 1 | 2018 | 10 | 0.160 |
Why?
|
| Receptors, Opioid | 1 | 2019 | 23 | 0.160 |
Why?
|
| Metabolism | 1 | 2018 | 24 | 0.160 |
Why?
|
| Ions | 1 | 2019 | 75 | 0.160 |
Why?
|
| Tobacco Smoking | 1 | 2019 | 29 | 0.160 |
Why?
|
| Genetic Testing | 1 | 2022 | 543 | 0.160 |
Why?
|
| Aged, 80 and over | 6 | 2020 | 6783 | 0.160 |
Why?
|
| Alzheimer Disease | 1 | 2023 | 515 | 0.150 |
Why?
|
| Exercise | 2 | 2021 | 328 | 0.150 |
Why?
|
| Muscle Contraction | 1 | 2019 | 286 | 0.150 |
Why?
|
| DNA, Mitochondrial | 1 | 2018 | 189 | 0.150 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2019 | 241 | 0.150 |
Why?
|
| Waist-Height Ratio | 1 | 2017 | 1 | 0.150 |
Why?
|
| Atlases as Topic | 1 | 2017 | 8 | 0.150 |
Why?
|
| Abortion, Therapeutic | 1 | 2017 | 11 | 0.150 |
Why?
|
| Stillbirth | 1 | 2017 | 10 | 0.150 |
Why?
|
| Solvents | 1 | 2017 | 97 | 0.140 |
Why?
|
| Naltrexone | 1 | 2019 | 137 | 0.140 |
Why?
|
| Epistasis, Genetic | 1 | 2018 | 90 | 0.140 |
Why?
|
| Dietary Exposure | 1 | 2017 | 2 | 0.140 |
Why?
|
| Chromosomes, Human | 1 | 2017 | 65 | 0.140 |
Why?
|
| Narcotic Antagonists | 1 | 2019 | 161 | 0.140 |
Why?
|
| DNA Helicases | 1 | 2017 | 84 | 0.140 |
Why?
|
| Surveys and Questionnaires | 3 | 2022 | 2655 | 0.140 |
Why?
|
| Abortion, Spontaneous | 1 | 2017 | 66 | 0.140 |
Why?
|
| Drinking | 3 | 2011 | 33 | 0.140 |
Why?
|
| Mutation | 2 | 2024 | 4168 | 0.140 |
Why?
|
| Creatinine | 1 | 2017 | 294 | 0.140 |
Why?
|
| Depressive Disorder | 1 | 2017 | 221 | 0.140 |
Why?
|
| Age Factors | 2 | 2018 | 1880 | 0.130 |
Why?
|
| Health Surveys | 3 | 2023 | 240 | 0.130 |
Why?
|
| DNA Copy Number Variations | 1 | 2017 | 181 | 0.130 |
Why?
|
| Parents | 1 | 2018 | 290 | 0.130 |
Why?
|
| Areca | 2 | 2013 | 9 | 0.130 |
Why?
|
| Follow-Up Studies | 4 | 2018 | 3678 | 0.130 |
Why?
|
| Heart Diseases | 2 | 2016 | 302 | 0.130 |
Why?
|
| Lead | 1 | 2015 | 28 | 0.120 |
Why?
|
| Dyspnea | 1 | 2016 | 76 | 0.120 |
Why?
|
| Precision Medicine | 1 | 2019 | 413 | 0.120 |
Why?
|
| Proteinuria | 1 | 2015 | 67 | 0.120 |
Why?
|
| Anxiety Disorders | 1 | 2016 | 152 | 0.120 |
Why?
|
| Mitochondria | 1 | 2018 | 556 | 0.120 |
Why?
|
| Fetal Blood | 1 | 2015 | 93 | 0.120 |
Why?
|
| Developing Countries | 1 | 2015 | 80 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2013 | 1929 | 0.120 |
Why?
|
| Illinois | 1 | 2016 | 485 | 0.120 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2015 | 98 | 0.120 |
Why?
|
| Germ-Line Mutation | 1 | 2017 | 347 | 0.120 |
Why?
|
| Phosphofructokinase-1, Muscle Type | 1 | 2014 | 9 | 0.110 |
Why?
|
| Chondromatosis | 1 | 1993 | 2 | 0.110 |
Why?
|
| Leiomyoma, Epithelioid | 1 | 1993 | 2 | 0.110 |
Why?
|
| Paraganglioma, Extra-Adrenal | 1 | 1993 | 12 | 0.110 |
Why?
|
| Anxiety | 1 | 2016 | 311 | 0.110 |
Why?
|
| Arm | 1 | 2014 | 99 | 0.110 |
Why?
|
| Mediastinal Neoplasms | 1 | 1993 | 46 | 0.110 |
Why?
|
| Depression | 1 | 2017 | 512 | 0.110 |
Why?
|
| Atrial Fibrillation | 1 | 2018 | 357 | 0.110 |
Why?
|
| Texas | 2 | 2024 | 116 | 0.110 |
Why?
|
| Multifactorial Inheritance | 1 | 2015 | 173 | 0.110 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 1993 | 103 | 0.110 |
Why?
|
| Overweight | 1 | 2014 | 119 | 0.110 |
Why?
|
| Vitamin E | 2 | 2014 | 32 | 0.100 |
Why?
|
| Keratosis | 1 | 2012 | 20 | 0.100 |
Why?
|
| Urinary Bladder | 1 | 2015 | 248 | 0.100 |
Why?
|
| Models, Statistical | 1 | 2016 | 576 | 0.100 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2015 | 450 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2012 | 47 | 0.100 |
Why?
|
| Gene Regulatory Networks | 1 | 2014 | 310 | 0.100 |
Why?
|
| Alleles | 4 | 2019 | 1137 | 0.100 |
Why?
|
| Double-Blind Method | 2 | 2013 | 1714 | 0.090 |
Why?
|
| Tremor | 1 | 2011 | 22 | 0.090 |
Why?
|
| Essential Tremor | 1 | 2011 | 6 | 0.090 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2015 | 366 | 0.090 |
Why?
|
| Methylation | 3 | 2019 | 269 | 0.090 |
Why?
|
| Tissue Fixation | 1 | 2010 | 40 | 0.090 |
Why?
|
| Skin | 1 | 2014 | 589 | 0.090 |
Why?
|
| Paraffin Embedding | 1 | 2010 | 78 | 0.090 |
Why?
|
| Formaldehyde | 1 | 2010 | 52 | 0.090 |
Why?
|
| Stomach Neoplasms | 1 | 1993 | 288 | 0.090 |
Why?
|
| Thyroid Hormones | 2 | 2023 | 330 | 0.090 |
Why?
|
| Protective Agents | 1 | 2010 | 34 | 0.090 |
Why?
|
| MicroRNAs | 1 | 2015 | 556 | 0.080 |
Why?
|
| Population Surveillance | 1 | 2011 | 216 | 0.080 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2022 | 539 | 0.080 |
Why?
|
| Water | 1 | 2011 | 286 | 0.080 |
Why?
|
| DNA | 1 | 2014 | 1311 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2008 | 42 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2008 | 79 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2008 | 85 | 0.080 |
Why?
|
| Protein Carbonylation | 1 | 2008 | 10 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2008 | 100 | 0.070 |
Why?
|
| Gene Frequency | 2 | 2019 | 687 | 0.070 |
Why?
|
| Gene Dosage | 1 | 2008 | 210 | 0.070 |
Why?
|
| Rural Population | 3 | 2014 | 147 | 0.070 |
Why?
|
| Ownership | 1 | 2007 | 26 | 0.070 |
Why?
|
| Sex Characteristics | 2 | 2019 | 328 | 0.070 |
Why?
|
| Chronic Disease | 1 | 2010 | 958 | 0.070 |
Why?
|
| Population Groups | 1 | 2006 | 41 | 0.070 |
Why?
|
| Cause of Death | 3 | 2013 | 269 | 0.070 |
Why?
|
| Risk Assessment | 3 | 2018 | 2327 | 0.060 |
Why?
|
| Chromosome Mapping | 1 | 2008 | 1074 | 0.060 |
Why?
|
| Genetic Research | 1 | 2024 | 18 | 0.060 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2024 | 54 | 0.060 |
Why?
|
| Metabolomics | 1 | 2024 | 76 | 0.060 |
Why?
|
| Computer Simulation | 2 | 2022 | 1102 | 0.060 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2024 | 63 | 0.060 |
Why?
|
| Vegetables | 2 | 2015 | 47 | 0.050 |
Why?
|
| Demography | 2 | 2015 | 183 | 0.050 |
Why?
|
| Postmenopause | 1 | 2023 | 102 | 0.050 |
Why?
|
| Particulate Matter | 1 | 2023 | 102 | 0.050 |
Why?
|
| Age of Onset | 2 | 2017 | 318 | 0.050 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2023 | 107 | 0.050 |
Why?
|
| Income | 1 | 2022 | 85 | 0.050 |
Why?
|
| Research Design | 1 | 2006 | 591 | 0.050 |
Why?
|
| Insulins | 1 | 2022 | 6 | 0.050 |
Why?
|
| Animals | 2 | 2019 | 27528 | 0.050 |
Why?
|
| Thyrotropin | 1 | 2022 | 289 | 0.050 |
Why?
|
| Lung Neoplasms | 1 | 1993 | 2370 | 0.050 |
Why?
|
| Accelerometry | 1 | 2021 | 40 | 0.040 |
Why?
|
| Triiodothyronine | 1 | 2022 | 346 | 0.040 |
Why?
|
| Thyroxine | 1 | 2022 | 355 | 0.040 |
Why?
|
| Michigan | 1 | 2020 | 54 | 0.040 |
Why?
|
| Waist-Hip Ratio | 1 | 2018 | 20 | 0.040 |
Why?
|
| Folic Acid | 1 | 2019 | 63 | 0.040 |
Why?
|
| Electronic Health Records | 1 | 2022 | 351 | 0.040 |
Why?
|
| Machine Learning | 1 | 2021 | 270 | 0.040 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2019 | 140 | 0.040 |
Why?
|
| Health Education | 1 | 2019 | 105 | 0.040 |
Why?
|
| Linkage Disequilibrium | 1 | 2019 | 477 | 0.040 |
Why?
|
| Estrogens | 1 | 2019 | 200 | 0.040 |
Why?
|
| Obesity, Abdominal | 1 | 2017 | 8 | 0.040 |
Why?
|
| Glutathione Transferase | 1 | 2018 | 112 | 0.040 |
Why?
|
| Lipoproteins, LDL | 1 | 2017 | 85 | 0.040 |
Why?
|
| Adipocytes | 1 | 2018 | 163 | 0.040 |
Why?
|
| Breast | 1 | 2019 | 292 | 0.040 |
Why?
|
| Mutation, Missense | 1 | 2019 | 281 | 0.040 |
Why?
|
| Adiposity | 1 | 2017 | 76 | 0.040 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2024 | 1098 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2019 | 557 | 0.040 |
Why?
|
| Receptors, Progesterone | 1 | 2018 | 175 | 0.030 |
Why?
|
| Triglycerides | 1 | 2017 | 233 | 0.030 |
Why?
|
| Longevity | 1 | 2017 | 58 | 0.030 |
Why?
|
| Genetics, Population | 1 | 2019 | 407 | 0.030 |
Why?
|
| Dyslipidemias | 1 | 2017 | 107 | 0.030 |
Why?
|
| Computational Biology | 1 | 2019 | 551 | 0.030 |
Why?
|
| Time Factors | 2 | 2015 | 5358 | 0.030 |
Why?
|
| Receptors, Estrogen | 1 | 2018 | 394 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2024 | 9210 | 0.030 |
Why?
|
| Self Report | 1 | 2017 | 297 | 0.030 |
Why?
|
| Glucose | 1 | 2018 | 629 | 0.030 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 2015 | 20 | 0.030 |
Why?
|
| Fruit | 1 | 2015 | 76 | 0.030 |
Why?
|
| Asia | 1 | 2014 | 102 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2018 | 961 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2015 | 303 | 0.030 |
Why?
|
| Data Collection | 2 | 2006 | 377 | 0.030 |
Why?
|
| Chemoprevention | 1 | 2014 | 92 | 0.030 |
Why?
|
| Comorbidity | 1 | 2018 | 953 | 0.030 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2015 | 137 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 283 | 0.030 |
Why?
|
| Causality | 1 | 2013 | 80 | 0.030 |
Why?
|
| Poverty | 1 | 2015 | 183 | 0.030 |
Why?
|
| Insulin | 1 | 2018 | 1148 | 0.030 |
Why?
|
| Spectrophotometry, Atomic | 1 | 2013 | 12 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2017 | 1497 | 0.030 |
Why?
|
| Disease Progression | 1 | 2018 | 1469 | 0.030 |
Why?
|
| Data Interpretation, Statistical | 1 | 2015 | 303 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2015 | 189 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 855 | 0.030 |
Why?
|
| Inflammation | 1 | 2019 | 981 | 0.030 |
Why?
|
| Respiratory Function Tests | 1 | 2013 | 140 | 0.030 |
Why?
|
| Organ Size | 1 | 2014 | 372 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2015 | 793 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2015 | 569 | 0.030 |
Why?
|
| Syndrome | 1 | 1993 | 450 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 885 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2013 | 194 | 0.030 |
Why?
|
| Tobacco, Smokeless | 1 | 2011 | 10 | 0.020 |
Why?
|
| Genomics | 1 | 2018 | 778 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2013 | 315 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2015 | 824 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 3252 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2018 | 744 | 0.020 |
Why?
|
| Food Analysis | 1 | 2011 | 4 | 0.020 |
Why?
|
| Community Health Planning | 1 | 2011 | 21 | 0.020 |
Why?
|
| Cucurbitaceae | 1 | 2010 | 4 | 0.020 |
Why?
|
| Cell Movement | 1 | 2015 | 787 | 0.020 |
Why?
|
| Fertilizers | 1 | 2010 | 8 | 0.020 |
Why?
|
| Mastication | 1 | 2011 | 78 | 0.020 |
Why?
|
| Genes, Neoplasm | 1 | 2010 | 38 | 0.020 |
Why?
|
| Sunlight | 1 | 2010 | 28 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 305 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2011 | 344 | 0.020 |
Why?
|
| Epidemiologic Methods | 1 | 2010 | 60 | 0.020 |
Why?
|
| Prognosis | 1 | 2018 | 3798 | 0.020 |
Why?
|
| Epidemiological Monitoring | 1 | 2010 | 39 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2010 | 161 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2010 | 277 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2010 | 371 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2015 | 2887 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2010 | 520 | 0.020 |
Why?
|
| Respiratory Tract Diseases | 1 | 2009 | 45 | 0.020 |
Why?
|
| Intelligence | 1 | 2009 | 71 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2015 | 2026 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2015 | 1670 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2010 | 899 | 0.020 |
Why?
|
| Apoptosis | 1 | 2015 | 1718 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2019 | 3404 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2010 | 726 | 0.020 |
Why?
|
| Nervous System Diseases | 1 | 2009 | 163 | 0.020 |
Why?
|
| Appendicitis | 1 | 1988 | 66 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2008 | 124 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2008 | 388 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2019 | 8273 | 0.020 |
Why?
|
| Haplotypes | 1 | 2008 | 637 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2007 | 206 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2008 | 785 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2008 | 872 | 0.020 |
Why?
|
| Proteins | 1 | 2010 | 787 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 1862 | 0.020 |
Why?
|
| Mice | 1 | 2019 | 11851 | 0.020 |
Why?
|
| Risk | 1 | 2006 | 657 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 2767 | 0.010 |
Why?
|
| RNA | 1 | 2007 | 583 | 0.010 |
Why?
|
| False Negative Reactions | 1 | 1988 | 63 | 0.000 |
Why?
|
| False Positive Reactions | 1 | 1988 | 223 | 0.000 |
Why?
|
| Acute Disease | 1 | 1988 | 846 | 0.000 |
Why?
|
| Ultrasonography | 1 | 1988 | 720 | 0.000 |
Why?
|